NewsRoom Articles - Page 34 of 214

FridayJul 19, 2024 10:00 am

Survey Shows Most US States Offer Medicare Advantage to Retirees

A new survey has determined that the share of employers who still provide health benefits to retirees has been decreasing over time, reaching 21% as of last year. The survey was carried out by Kaiser Family Foundation (KFF), a leading health policy organization in the United States. The survey’s objective was to examine the extent to which states were offering health benefits to eligible retirees under Medicare, via Medicare Advantage arrangements. This analysis was based on KFF’s review of employee-retirement-system sites for different states. The survey determined that almost all the states along with the District of Columbia offer health…

FridayJul 19, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Announces New Data From Phase III Study of Buntanetap for Early Parkinson’s Disease

The study shows buntanetap is effective in enhancing both motor and cognitive functions, as well as non-motor activities in Parkinson’s Disease patients Following the announcement of these positive results, the company’s stock price surged by 76% The data revealed that while 12% of Parkinson’s Disease patients showed cognitive decline, buntanetap not only halted this decline but also led to improvements Annovis held a webcast to go over the results in more depth, which is available for replay on the company’s website Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s…

ThursdayJul 18, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Plan to Submit Briefing Book to FDA Preceding Type C Interaction

Clene plans to submit a briefing book to the U.S. Food and Drug Administration by July 13 as Part of Overall Process to Support Approval for CNM-Au8(R) for Treatment of ALS Type C interaction is aimed at obtaining FDA feedback on the potential pathway for a new drug application for CNM-Au8 as a treatment for ALS via the accelerated approval process The briefing book includes new post-hoc analyses of data from completed clinical trials and addresses comments made by the FDA during a previous meeting in late 2023 Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage…

WednesdayJul 17, 2024 10:00 am

Women with Autism Have Higher Odds of Being Misdiagnosed with BPD

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that has been identified to occur at different levels of severity. Patients with this disorder are sometimes misdiagnosed, because its symptoms overlap with other disorders. It is said that women are less likely to be accurately diagnosed with autism during their lifetimes, with most being misdiagnosed with borderline personality disorder (BPD) or other disorders before they are diagnosed with autism. A possible explanation is that young girls learn how to fit in and get along with others early. Focusing on social interaction may enable them to camouflage their autism symptoms, which keeps…

WednesdayJul 17, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Files New Composition of Matter Patent for Buntanetap

Annovis has filed a new composition of matter patent with the U.S. Patent and Trademark Office covering novel solid forms of buntanetap, selecting the best crystal, and building upon the provisional patent filed in June 2023 The company’s research focuses on inhibiting the production of multiple neurotoxic proteins that contribute to the progression of neurodegenerative diseases Annovis continues to expand its position in an ongoing fight against neurodegenerative diseases Annovis Bio (NYSE: ANVS), a pioneering biotechnology company, committed to addressing unmet medical needs through innovative research and development efforts, particularly in Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions, is…

MondayJul 15, 2024 10:00 am

Study Suggests Vitamin B Deficiency Could Be Pivotal in Parkinson’s Disease

Latest figures from the World Health Organization show that more than 8.5 million individuals around the globe are living with Parkinson’s disease. This disease is the fastest-growing neurodegenerative disorder globally, with the number of individuals with this illness more than doubling since 1990. The risk of developing this condition heightens with age; in addition, men are 50% more likely than women to develop the disease. Other risk factors include past traumatic brain injury, exposure to environmental toxin and genetics. Primary symptoms of the condition include muscle stiffness, tremors, impaired coordination and balance, gastrointestinal symptoms and emotional changes, among others. Prior…

FridayJul 12, 2024 10:00 am

Study Explores Starving Malignant Cells to Boost Immunotherapy, Improve DNA Damage

Prostate cancer is challenging to treat, especially when the disease progresses to a castrate-resistant metastatic state. Conventional treatments, such as hormonal treatments, radiotherapy and chemotherapy, fail most times because of acquired resistance, off-target effects and toxicities. It is well-known that amino acids perform important metabolic functions. While normal cells have lower demand for amino acids, cancer cells exhibit high demand for amino acids because of increased demand for cellular building blocks and energy. Now a new study has determined that starving cancer cells may help improve immunotherapy response and increase damage to DNA, which in turn helps speed up death…

WednesdayJul 10, 2024 10:00 am

30 Years Later, Amazon Now Dominates eCommerce

On July 5,1994, Jeff Bezos founded Amazon as a bookselling business in his garage. Three decades later, Amazon is one the largest companies globally. The company’s value currently stands at $2.08 trillion. Let’s look at the company’s trajectory, from the beginning to its current position in the global markets. Who was Bezos prior to founding Amazon? In 1994, Bezos was a Wall Street investment banker who wanted to be part of the dot.com boom. He was focused and intense, despite being a frugal individual who drove a Honda and wore khakis. His objective was to build a store that carried…

MondayJul 08, 2024 12:00 pm

Astiva Health Inc. Leading the Way as Record Number of People Choose Medicare Advantage Plans

For the first time in Medicare’s history, more than half of all eligible people with Medicare are enrolled in private Medicare Advantage plans Enrollment in Medicare Advantage programs is projected to grow from 54% of the eligible population in 2024 to 60% by the end of the decade Astiva Health has developed one of the most diverse networks in Southern California and offers a selection of benefits tailored to the specialized needs of its members According to a recent KFF report, a record number of people enrolled in private Medicare Advantage plans last year (https://ibn.fm/YEpRJ). That trend bodes well for Astiva Health,…

MondayJul 08, 2024 10:00 am

Research Identifies How Glioblastoma Develops Resistance to Immunotherapy

Glioblastoma multiforme is an aggressive cancer that grows quickly and spreads rapidly, originating as a growth of cells in the spinal cord or the brain. Researchers at the University of Copenhagen may have discovered how this type of cancer, which primarily effects adults, develops resistance to immunotherapy. At first, the researchers thought that the cancer cells changed their DNA via mutation, helping them become treatment resistant. However, the researchers observed that when glioblastoma cells were subjected to immunotherapy, they behaved differently. Joachim Lütken Weischenfeldt, a clinical professor at the Biotech Research and Innovation Center, led this research. For their study,…